Prostate cancer: no/incomplete PSA testing linked to high-risk disease in older men
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Almost half of older men undergoing radiotherapy for prostate cancer had no/incomplete prostate-specific antigen (PSA) testing.
- No/incomplete PSA testing was associated with high-risk disease.
Why this matters
- Consider screening healthy older men who are likely to benefit from early detection and treatment.
- 54.0% underwent PSA testing with appropriate follow-up biopsy, 26.3% underwent PSA testing without biopsy, and 19.7% received no PSA testing.
- Odds of PSA testing decreased by 20% with each additional year of age (P<.001).
- PSA testing rates did not significantly differ before vs after the 2008 US Preventive Services Task Force recommendations (P=.91).
- Men without PSA testing were more likely to be diagnosed with higher stage disease (P=.002).
- PSA-tested cohort was significantly ...